Senior insider sale
EVP & Chief Commercial Officer at COLLEGIUM PHARMACEUTICAL, INC — senior position signals high conviction
$847.9K
17.60K shares
What this filing means
DREYER SCOTT plans to sell 17.60K shares of COLLEGIUM PHARMACEUTICAL, INC valued at approximately $847.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/8/2025ACC: 0001959173-25-007573
Officer· EVP & Chief Commercial Officer
Since Jul 2018
17.60K
Shares to sell
$847.9K
Approx. market value
17.60K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Options Granted - 01/25/2019
Cash
12/8/2025
17.60KTotal acquired17.60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/8/2025 | Options Granted - 01/25/2019 Cash | 17.60K | — |
| Total | 17.60K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
17.60K
Market value
$847.9K
12/8/2025
Total
Units
17.60K
Value
$847.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/8/2025 | 17.60K | $847.9K | NASDAQ | Planned |
| Total | 17.60K | $847.9K | ||